Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bolger

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Journal of Pharmaceutical Sciences|November 13, 1998
Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1M B Bolger, I S Haworth, A K Yeung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 1999
Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of PepT1V H Lee, C Chu, E D Mahlin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 12, 2020
Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: OrBiTo consortium commentaryMasoud Jamei, Bertil Abrahamsson, Jonathan Brown, et al.
Journal of Medicinal Chemistry|January 3, 1997
Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptorD J Hogenkamp, S H Tahir, J E Hawkinson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 25, 2013
PBPK models for the prediction of in vivo performance of oral dosage formsEdmund S Kostewicz, Leon Aarons, Martin Bergstrand, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptorR B Carter, P L Wood, S Wieland, et al.
Human Mutation|May 28, 2010
Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma familiesSusana Igreja, Harvinder S Chahal, Peter King, et al.
Clinical Genitourinary Cancer|April 15, 2015
Effect of African-American Race on Tumor Recurrence After Radical Cystectomy for Urothelial Carcinoma of the BladderRavi K Paluri, Charity J Morgan, David J Mooney, et al.
American Journal of Respiratory Cell and Molecular Biology|October 11, 2013
Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitisJames A Lambert, S Vamsee Raju, Li Ping Tang, et al.
Biochemical and Biophysical Research Communications|September 15, 1998
Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton- coupled dipeptide transporter (hPepT1)A K Yeung, S K Basu, S K Wu, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Journal of Pharmaceutical Sciences|November 13, 1998
Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1M B Bolger, I S Haworth, A K Yeung, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 1999
Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of PepT1V H Lee, C Chu, E D Mahlin, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 12, 2020
Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: OrBiTo consortium commentaryMasoud Jamei, Bertil Abrahamsson, Jonathan Brown, et al.
Journal of Medicinal Chemistry|January 3, 1997
Synthesis and in vitro activity of 3 beta-substituted-3 alpha-hydroxypregnan-20-ones: allosteric modulators of the GABAA receptorD J Hogenkamp, S H Tahir, J E Hawkinson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 25, 2013
PBPK models for the prediction of in vivo performance of oral dosage formsEdmund S Kostewicz, Leon Aarons, Martin Bergstrand, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptorR B Carter, P L Wood, S Wieland, et al.
Human Mutation|May 28, 2010
Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma familiesSusana Igreja, Harvinder S Chahal, Peter King, et al.
Clinical Genitourinary Cancer|April 15, 2015
Effect of African-American Race on Tumor Recurrence After Radical Cystectomy for Urothelial Carcinoma of the BladderRavi K Paluri, Charity J Morgan, David J Mooney, et al.
American Journal of Respiratory Cell and Molecular Biology|October 11, 2013
Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitisJames A Lambert, S Vamsee Raju, Li Ping Tang, et al.
Biochemical and Biophysical Research Communications|September 15, 1998
Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton- coupled dipeptide transporter (hPepT1)A K Yeung, S K Basu, S K Wu, et al.
Pageof 14